crown

Subscribe Now

FOLLOW US

Sign in

Fda News

PAGE 7

Moderna vaccine found safe, effective ahead of FDA review

Moderna’s vaccine isn’t yet approved in any other countries and hasn’t yet been used on anyone outside of a clinical trial.

Published on Dec 15, 2020, 7:36 PM IST

US set for first Covid-19 shots as shipments begin arriving

US Marshalls walk on the tarmac Sunday, Dec. 13, 2020, while guarding the first shipment of Pfizer-BioNTech Covid-19 vaccines as they are transferred from a truck to a UPS cargo jet at Capital Region International Airport in Lansing, Mich.

Published on Dec 14, 2020, 7:57 PM IST

UPS, FedEx collaborate to ship Pfizer-BioNTech Covid-19 vaccines in US

“This is the moment we’ve been waiting for... We’ve been planning for months with daily calls, drilling down to really quite minute details,” said Wes Wheeler, president of UPS’s health care division

Updated on Dec 13, 2020, 11:37 AM IST

After FDA nod, Trump says US vaccine roll-out in ‘less than 24 hours’

FDA Commissioner Stephen Hahn listens as President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorisation for blood plasma as a coronavirus treatment during a press conference in August.

Updated on Dec 12, 2020, 11:32 AM IST

US FDA nod may give Pfizer’s approval case in India a boost

A medic administers COVAXIN, an Indian government-backed experimental COVID-19 vaccine, to a health worker during its trials, at the Gujarat Medical Education & Research Society in Ahmedabad.

Updated on Dec 12, 2020, 7:32 AM IST

US Covid-19 vaccine near, but deaths rising by 9/11 proportions each day

A mock vial of the Pfizer vaccine for the coronavirus disease (Covid-19) is shown during a staff vaccine training session at UW Health in Madison, Wisconsin, US on December 8, 2020.

Updated on Dec 11, 2020, 9:23 PM IST

Covid-19 is far more dangerous than any vaccine

The risks are also tiny compared to the economic insecurity, lost education and deep isolation brought on by the pandemic and our interventions to try to stop it.

Updated on Dec 10, 2020, 10:29 PM IST

Covid-19: What you need to know today

Simon Stevens (R), Chief Executive of the NHS, watches as a nurse (C) administers a dose of the Pfizer-BioNTech Covid-19 vaccine to Frank Naderer (L), 82, at Guy’s Hospital in London on December 8, 2020 as the UK starts its biggest ever vaccination programme.

Updated on Dec 10, 2020, 7:11 AM IST

Pfizer Covid-19 vaccine’s effect on transmission still unknown, FDA says

The FDA report was issued ahead of a Thursday meeting of outside advisers to the agency, whose deliberations will inform whether the vaccine is cleared for U.S. use.

Updated on Dec 8, 2020, 9:32 PM IST

Covid-19: What is a placebo? Why is it used in vaccine trials?

Haryana health minister Anil Vij undergoing the final trial of the Covid-19 vaccine at Civil Hospital, Ambala Cantonment.

Updated on Dec 6, 2020, 7:18 PM IST

Covid-19: What side effects to expect from a vaccine shot? Will it be more painful than flu vaccine?

A medic of the regional hospital receives Russia's Sputnik-V vaccine shot against the coronavirus disease (Covid-19).

Updated on Dec 4, 2020, 9:13 PM IST

How are vaccines approved: All you need to know

The United Kingdom became the first country to approve the Covid-19 vaccine created by Pfizer and BioNTech for emergency usage

Updated on Dec 3, 2020, 6:50 PM IST

US top health expert criticises UK’s approval of Pfizer Covid-19 vaccine. Here’s the reason

Dr Anthony Fauci opined that the UK regulators did not scrutinise the data as carefully as the FDA is carrying out in its review.

Updated on Dec 3, 2020, 6:50 PM IST

Merck sells stake in Moderna as Covid-19 vaccine gets FDA review

Based in Cambridge, Massachusetts, Moderna is developing one of the fastest-moving potential coronavirus vaccines. The shot is slated for review by U.S. regulators in the coming weeks.

Updated on Dec 3, 2020, 12:22 AM IST

Moderna files for US vaccine authorization, will seek EU nod

The US Food and Drug Administration said an advisory committee would meet to discuss the request on Dec. 17.

Updated on Dec 1, 2020, 6:46 AM IST

Novavax’s stocks gain after Covid-19 vaccine study in UK fully enrolled

Novavax has surged more than 3,160% this year. Its program is backed by the USD1.6 billion funding from the US government’s Operation Warp Speed.

Updated on Nov 30, 2020, 11:09 PM IST

From frontline workers to all residents: How US’ 5-phase Covid-19 vaccination may work

The distribution of Covid-19 vaccine has to be prioritised because of the limited supply of doses.

Updated on Nov 30, 2020, 6:08 PM IST

Beware of Covid-19 scams as vaccine approaches FDA approval

FILE - In this Wednesday, Aug. 5, 2020 file photo, healthcare workers perform tests in a tent at a drive-thru Covid-19 testing site in Antwerp, Belgium.

Updated on Nov 30, 2020, 5:32 PM IST

Opinion | Coronavirus pandemic: India should give emergency approval for the Covid-19 vaccine

Wife of a 57-year-old coronavirus disease (COVID-19) victim wails as she looks at the body of her husband before he is being taken for the cremation by the members of the Shaheed Bhagat Singh Sewa Dal, in New Delhi, India, November 26, 2020.

Updated on Nov 27, 2020, 4:32 PM IST

EU drugs watchdog expects first application for Covid-19 vaccine in days

The EMA started a real-time review of the Pfizer-BioNTech vaccine on October 6.

Updated on Nov 26, 2020, 5:56 PM IST

AstraZeneca’s Covid-19 vaccine less effective when given in bigger doses: Report

AstraZeneca and Oxford reported results after 131 trial participants in the U.K. and Brazil contracted Covid 19. The average efficacy of 70% prevention sounded good, within the expectations of analysts and above a 50% standard the FDA had set for Covid vaccines.

Updated on Nov 24, 2020, 11:01 AM IST

US expects to start Covid-19 vaccination program in early December: Official

Pfizer Inc. and BioNTech SE have submitted to FDA for emergency use authorisation.

Updated on Nov 22, 2020, 9:44 PM IST

Covid-19 vaccine updates: How Pfizer/BioNTech vaccine candidate has taken the lead

American pharmaceutical giant Pfizer and its German partner BioNTech are racing against time to get their vaccine for the coronavirus disease approved

Published on Nov 21, 2020, 7:31 PM IST

Coronavirus: Remdesivir’s failure is a warning for Covid-19 vaccines

FILE - In this Thursday Oct. 15, 2020 file photo, A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary. Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. The World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines. (Representational)

Updated on Nov 21, 2020, 10:49 AM IST

Coronavirus: What does emergency use of a Covid-19 vaccine mean?

FILE PHOTO: A researcher works in a lab run by Moderna Inc, who said November 16, 2020 that its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, in an undated still image from video. (Representational)

Updated on Nov 21, 2020, 10:13 AM IST

Coronavirus pandemic: Can surgical masks be reused?

Representational image

Updated on Nov 20, 2020, 11:13 PM IST

Pfizer seeks emergency use of its Covid-19 vaccine in US

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe Covid-19 disease in a large, ongoing study.

Updated on Nov 20, 2020, 5:51 PM IST

Pfizer and BioNTech to seek emergency Covid-19 vaccine approval in US Friday

The BioNTech/Pfizer shot and another one being developed by US firm Moderna have taken the lead in the global chase for a vaccine against the coronavirus disease.

Published on Nov 20, 2020, 8:01 AM IST

FDA to make emergency use authorization data public for Covid-19 vaccines

FDA believes disclosing such information would also contribute to the public’s confidence in the agency’s rigorous review of scientific data.

Published on Nov 17, 2020, 11:07 PM IST

‘On my watch!’: Trump boasts about Moderna’s Covid-19 vaccine efficacy

Moderna intends to submit for an Emergency Use Authorization with FDA in the coming weeks.

Updated on Nov 16, 2020, 11:10 PM IST

7

Home / Topic / Fda / News

© 2026 HindustanTimes